A novel missense mutation in the C-terminal domain of lipoprotein lipase (Glu410–>Val) leads to enzyme inactivation and familial chylomicronemia.
Lipoprotein lipase (LPL) is a complex enzyme consisting of multiple functional domains essential for the initial hydrolysis of triglycerides present in plasma lipoproteins. Previous studies have localized the catalytic domain of LPL, responsible for the hydrolytic function of the enzyme, to the N-te...
Main Authors: | L Previato, O Guardamagna, K.A Dugi, R Ronan, G.D. Talley, S Santamarina-Fojo, H.B. Brewer, Jr. |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
1994-09-01
|
Series: | Journal of Lipid Research |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0022227520411538 |
Similar Items
-
Functional characterization of a chimeric lipase genetically engineered from human lipoprotein lipase and human hepatic lipase
by: HL Dichek, et al.
Published: (1993-08-01) -
Lipoprotein Lipase Deficiency in an Infant With Chylomicronemia, Hepatomegaly, and Lipemia Retinalis
by: Dinesha Maduri Vidanapathirana MBBS, Dip Chem Path, et al.
Published: (2017-06-01) -
Modifications of plasma lipoproteins after lipase activation in patients with chylomicronemia.
by: E Manzato, et al.
Published: (1990-05-01) -
Familial chylomicronemia due to a circulating inhibitor of lipoprotein lipase activity
by: J D Brunzell, et al.
Published: (1983-01-01) -
ApoC-IIParis2: a premature termination mutation in the signal peptide of apoC-II resulting in the familial chylomicronemia syndrome.
by: CL Parrott, et al.
Published: (1992-03-01)